Atrás
Rango del Día
$58.15
$60.33
Rango de 52 Semanas
$30.82
$99.50
Volumen
548,704
Promedio 50D / 200D
$69.78
/
$69.77
Cierre Anterior
$59.11
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -10.7 | 0.3 |
| P/B | 3.1 | 2.9 |
| ROE % | -35.9 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$110.25
+85.0%
Low: $75.00
High: $153.00
EPS Futuro
-$6.89
Ingresos Est.
3.2 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$1.47
$0.72 – $3.40
|
560 M | 4 |
| FY2029 |
-$2.92
-$6.74 – -$1.43
|
350 M | 4 |
| FY2028 |
-$5.47
-$7.76 – -$2.57
|
140 M | 10 |
Puntos Clave
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -181.33M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-35.86%
ROIC-23.87%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.00
Current Ratio21.94
Interest Coverage-65.43
Valoración
P/E Ratio
-10.72
P/B Ratio3.07
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -212.18M |
| ROE | -35.86% | ROA | -26.30% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -181.33M |
| ROIC | -23.87% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 21.94 |
| Interest Coverage | -65.43 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -10.72 | P/B Ratio | 3.07 |
| P/S Ratio | N/A | PEG Ratio | -0.26 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.27B | Enterprise Value | 2.19B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -212.18M | -109.36M | -76.43M | -46.83M | -35.97M |
| EPS (Diluted) | -6.01 | -3.96 | -3.42 | -45.05 | -44.88 |
| Gross Profit | -281,000.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -236.02M | -129.72M | -91.13M | -47.48M | -30.93M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 806.88M | 496.77M | 368.00M | 200.21M | 92.41M |
| Total Liabilities | 67.05M | 53.19M | 22.88M | 23.61M | 156.61M |
| Shareholders' Equity | 739.83M | 443.59M | 345.12M | 176.60M | -64.20M |
| Total Debt | 1.86M | 30.00M | 2.10M | 1.33M | 7.06M |
| Cash & Equivalents | 91.15M | 192.43M | 360.38M | 194.61M | 88.04M |
| Current Assets | 803.90M | 493.62M | 365.66M | 198.49M | 90.48M |
| Current Liabilities | 36.64M | 23.32M | 21.44M | 22.58M | 13.42M |